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Reliability of self reported smoking status by pregnant
women for estimating smoking prevalence: a retrospective,
cross sectional study
Deborah Shipton, career development fellow,1 David M Tappin, director of paediatric epidemiology and
community health (PEACH) unit,2 Thenmalar Vadiveloo, PhD student,3 Jennifer A Crossley, consultant clinical
scientist,3 David A Aitken, consultant clinical scientist,3 Jim Chalmers, consultant in public health medicine4
ABSTRACT
Objective To determine what impact reliance on self
reported smoking status during pregnancy has on both
the accuracy of smoking prevalence figures and access to
smoking cessation services for pregnant women in
Scotland.
Design Retrospective, cross sectional study of cotinine
measurements in stored blood samples.
Participants Random sample (n=3475) of the 21029
pregnant women in the West of Scotland who opted for
second trimester prenatal screening over a one year
period.
Main outcome measure Smoking status validated with
cotinine measurement by maternal area deprivation
category (Scottish Index of Multiple Deprivation).
Results Reliance on self reported smoking status
underestimated true smoking by 25% (1046/3475 (30%)
from cotinine measurement v 839/3475 (24%) from self
reporting, z score 8.27, P<0.001). Projected figures
suggest that in Scotland more than 2400 pregnant
smokers go undetected each year. A greater proportion of
smokers in the least deprived areas (deprivation
categories 1+2) did not report their smoking (39%)
comparedwithwomen in themost deprived areas (22% in
deprivation categories 4+5), but, because smoking was
far more common in the most deprived areas (706 (40%)
in deprived areas compared with 142 (14%) in affluent
areas), projected figures for Scotland suggest that twice
as many women in the most deprived areas are
undetected (n=1196) than in the least deprived areas
(n=642).
Conclusion Reliance on self reporting to identify pregnant
smokers significantly underestimates the number of
pregnant smokers in Scotland and results in a failure to
detect over 2400 smokers each year who are therefore not
offered smoking cessation services.
INTRODUCTION
Although the risks of smoking during pregnancy for
both mother and child are well established,1 smoking
during pregnancy is still common, with smoking rates
varying from 24% in Scotland2 to 17% in England.3
Smoking prevalence generally increases with depriva-
tion, and this is certainly true of Scotland,where 41%of
women in the most deprived areas report smoking
compared with only 14% in the least deprived areas.4
Alarmingly, the gap in smoking prevalence between
deprivation areas is larger in the pregnant population,
where smoking is reduced to 8% in the least deprived
areas but to only 38% in the most deprived area (data
from the Scottish Morbidity Record (SMR02) for
2005, provided by NHS Information Services Divi-
sion, www.isdscotland.org).
Self reported smoking is commonly used in antena-
tal clinics to determine the smoking status of pregnant
women.However, this is an inaccuratemethodof iden-
tifying smokers,5 with studies suggesting up to a quar-
ter of pregnant smokers aremissedwhen self reporting
is relied on.6-8 The accuracy of self report varies by the
setting in which the questions are asked. Routinely col-
lected data, such as in antenatal care, is often less accu-
rate than data collected in settings perceived as more
neutral, such as in research interviews.9Withmounting
social andmedical pressure onwomen to quit smoking
during pregnancy, there is greater likelihood that preg-
nant women will not report their smoking. Such inac-
curacy can affect the reliability of smoking prevalence
figures and access to smoking cessation services.
National targets to improve the nation’s health gen-
erally include targets to reduce smoking during
pregnancy,10 11 often with the explicit aim of reducing
inequalities related to deprivation. The Scottish gov-
ernment uses self reported smoking atmaternity book-
ing to construct targets and to measure the success of
services in reaching such targets. Thesemeasures need
to be robust in order to assess if services are achieving
their aim and if money is being well spent in trying to
achieve these targets.
Smoking cessation interventions have been shown
to be moderately effective in reducing continued
smoking into late pregnancy, with a risk of smoking
for the intervention group relative to the control
group of 0.94.12 Perhaps more importantly inter-
vention is effective at reducing the proportion of babies
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of low birth weight (relative risk 0.81 (95% CI 0.70 to
0.94)) and of preterm births (0.84 (0.72 to 0.98)), and at
increasing birth weight (33 g (11 g to 55 g) increase in
weight).12 These findings have helped promote the
development of smoking cessation programmes direc-
ted at pregnantwomen.13 Entry to such specialist cessa-
tion services in Scotland, however, usually depends on
self reporting of smoking at the maternity booking
visit.14 Therefore, unless a woman admits to being a
current smoker at maternity booking she will not be
referred to specialist smoking cessation services and
will not receive appropriate support, putting her own
health and the health of her unborn child at risk. This
study aimed to assess the robustness of self reporting at
maternity booking as a method to set targets and to
identify pregnant smokers.
Few studies have looked at the variation in accuracy
of self reported smoking by deprivation, although the
education level of pregnant women has been linked to
the accuracy of self reporting.15 We hypothesised that
self reporting is less effective at identifying smokers in
the most deprived areas compared with identifying
those in more affluent areas, and that this further com-
pounds existing health disparities during pregnancy.16
We compared the routinely collected self reported
smoking status of pregnant women with their smoking
status validated by means of serum cotinine measure-
ment in order to: use the validated smoking prevalence
in the study population to estimate the true smoking
prevalence in pregnant women in Scotland; to identify
the number of pregnant women in the study popula-
tion who smoked but had no access to smoking cessa-
tion services in order to estimate the number of such
women in Scotland; and to identify any variation in the
level of under-reporting of smoking by area depriva-
tion and determine what impact this will have on exist-
ing health inequalities in pregnancy.
METHODS
Sample
The records of all women in theWest of Scotland who
opted for prenatal screening in the second trimester for
Down’s syndrome and neural tube defects between
May 2003 and July 2004 (that is, likely to result in a
2004 birth) were matched with their obstetric records
from the Scottish Morbidity Records (SMR02) (data
for 2004, provided byNHS Information ServicesDivi-
sion, www.isdscotland.org). The prenatal screening
process involves measuring maternal serum α fetopro-
tein and human chorionic gonadotrophin. Excess
serum is stored at −20°C. At the time of linking, 2004
was the most recent complete year in the SMR02 data-
set. The SMR02 data contain self reported smoking
information collected by the midwife at the maternity
booking appointment, usually carried out at
8-12 weeks of gestation, for all women delivering in
an NHS facility.Women were asked for their smoking
status and were recorded as current, former, or never
smokers (or unknown if the response was not
recorded). Information on the baby’s date of birth,
mother’s date of birth, maternal area deprivation
(Scottish Index of Multiple Deprivation, which is
based on postcode of residence reflecting material
deprivation)17 and date of booking was also available
in the SMR02 data. Second trimester prenatal screen-
ing was usually carried out at 15-16 weeks of gestation.
The records were matched using the mother’s sur-
name, forename, date of birth, and hospital number
using probability matching techniques.18 After data
linkage, the database was returned with all patient-
identifiable information removed and samples
selected for cotinine measurement.
A simple random sample of linked records was
selected for cotinine analysis from the births in the
2004 calendar year.
Sample size
A sample size of 3200 records allowed a 3% difference
in the proportion of cotinine validated smoking and
self reported smoking to be detected in the sample as
a whole and a difference of 3% to be detected when
comparing the combined deprivation categories 1
and 2 with the combined categories 4 and 5. We
made the a priori decision to collapse the two highest
and two lowest deprivation categories to give a greater
power with the chosen sample size. To allow for tech-
nical difficulties (such as insufficient serum, etc), 3550
women were randomly selected from the linked data-
set for cotinine analysis.
Cotinine analysis
As cotinine is derived only from nicotine metabolism,
its measurement in serum is a good indicator of recent
nicotine exposure. Cotinine testing was carried out on
thawed serum samples at the West of Scotland Regio-
nal Genetics Service laboratories using commercially
available kits (Cozart STDMicro-Plate Cotinine EIA),
and those performing the tests were blind to the
women’s reported smoking status. Samples were
assayed in singletons only. Samples with cotinine con-
centrations between 10 and 30 ng/ml (close to the cut-
off value) were re-assayed and the mean of the two
values taken as the final cotinine concentration. Coti-
nine concentrations≥13.7ng/mlwere taken to indicate
current smoking.19
Statistical analysis
The prevalences of cotinine validated current smoking
and self reported current smokingwere determined for
the whole sample, and by area deprivation categories,
and statistically compared (one-sample test of equality
of proportions) using STATA (version 8).
The number of cotinine validated smokers not cap-
tured by self reporting (referred to as undetected smo-
kers) was determined by identifying women with
never, former, or unknown smoking status who had
cotinine values ≥13.7 ng/ml, for the whole sample
and by deprivation category.
The degree to which the study sample represents the
population from which the sample was drawn and the
population of pregnant women in Scotland was
RESEARCH
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determined by comparing the distribution of maternal
age, deprivation category, and self reported smoking
status in the study sample with the population of preg-
nant women in the West of Scotland who opted to be
screened, the total pregnant population in the West of
Scotland (including those who did not opt for screen-
ing), and the population of pregnant women in Scot-
land. Cotinine validated smoking prevalence in the
study sample was used to estimate the true smoking
prevalence in the population of pregnant women in
Scotland, accounting for differences in the distribution
of deprivation, maternal age, and self reported smok-
ing status using standardisation techniques. For exam-
ple, the estimated number of cotinine validated
pregnant smokers in Scotland aged <20 in deprivation
categories 1 and 2 who reported never smoking would
be calculated by multiplying the proportion of such
women in the study sample by the number of pregnant
women aged <20 in deprivation categories 1 and 2
reporting never smoking in the Scottish pregnant
population. Scottish Morbidity Records (SMR02)
data were used to project figures for Scotland.
The number of undetected smokers was estimated
by subtracting the number of smokers identified by
self reporting from the estimated number of true smo-
kers. Fifty women with no data on deprivation cate-
gory or age were excluded, leaving 52591 pregnant
women in Scotland with a 2004 birth. In generating
the projected estimates for Scotland, we collapsed the
maternal age categories (to <24, 25-29, 30-34 and
≥35 years) and the highest and lowest deprivation cate-
gories (1+2 and 4+5) because of small numbers in the
sample population.
Statistical significanceof differences between catego-
rical variables was determined with Pearson’s χ2 test.
All analyses were performedwith SPSS (version 15) or
STATA (version 8). To explore the sensitivity of the
findings to the cotinine concentration we used in this
study to denote a current smoker, we repeated the ana-
lyses using alternative cotinine levels found in the lit-
erature.
Ethical approval and data protection
We contacted the Central Office for Research Ethics
Committees (corec.org.uk), which advised that ethical
approvalwas not needed for the study.Data protection
issues were discussedwith the data protection officer at
the University of Glasgow and a confidentiality state-
ment for use of NHS patient data was completed. The
Privacy Advisory Committee of the Information Ser-
vices Division (ISD) of NHS National Services
approved the study for linkagewith routinely collected
data held by ISD.
RESULTS
Of the 29975women in theWest of Scotlandwho gave
birth in 2004, 21029 (70%) opted for second trimester
screening.Of these, 97% could be linked to their obste-
tric SMR02 data and 3550 were randomly selected for
cotinine analysis; 98% of samples were located and
assayed (fig 1). Seventy one serum samples with coti-
nine concentration of 10-30 ng/ml (close to the cut-off
value) were re-analysed.
Over half of the 3475 women in the sample reported
never smoking, and just less than a quarter reported
being current smokers. The self reported smoking sta-
tus was unknown for 9% of the study population
(table 1). The profile of maternal age, baby’s birth
weight, and gestation at delivery were all typical of
that seen in Scotland.20 Women in deprived areas
were over-represented in this sample, as in theWest of
Scotland.17
Under-reporting of smoking in the sample population
According to the figures for self reported smoking sta-
tus, 839 (24.1%) of the pregnant women were current
smokers. This value is significantly lower than the coti-
nine validated estimate of 1046 (30.1%) who were cur-
rent smokers (table 2). As expected, the prevalence of
smoking in the most deprived categories was greater
than in the least deprived categories, with both the
self reported and cotinine validated estimates. How-
ever, the difference between the cotinine validated
and self reported smoking estimates is greater in the
Women in West of Scotland with a 2004 birth (n=29 975)
Opted for prenatal screening (n=21 029)
Records randomly selected for analysis (n=3550)
Serum samples located and analysed (n=3475)
Screening records that could be linked to Scottish
Morbidity Records (SMR02) maternity data (n=20 283)
Fig 1 | Selection of study sample for cotinine analysis
Table 1 | Basic characteristics of 3475 pregnant women in the
West of Scotland and their subsequent babies. (Values are
numbers (percentages) unless stated otherwise)
Characteristic Value
Self reported smoking status inpregnancy:
Current smoker 839 (24.1)
Former smoker 367 (10.6)
Never smoker 1971 (56.7)
Unknown 298 (8.6)
Mean (SD) maternal age (years)* 29.4 (6.0)
Mean (SD) gestation at delivery (weeks) 39.2 (2.0)
Mean (SD) birth weight of baby (g) 3390.8 (600.0)
Deprivation category†:
1 (least deprived) 440 (12.7)
2 545 (15.7)
3 733 (21.1)
4 730 (21.0)
5 (most deprived) 1023 (29.5)
*Data missing for one record.
†Based on Scottish Index of Multiple Deprivation. Data missing for four
records.
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most deprived groups than in the least deprived groups
(table 2).
Sixty one (7%) of the self reported smokers had coti-
nine concentrations below the cut-off value for current
smoking, and were therefore classified as non-smokers
(table 3). These women could have quit between their
booking and screening appointments, have been light
smokers, or be recording errors.
The proportion of cotinine validated current smo-
kers who were correctly identified by self reporting
was 74.4%. This means that 25.6% (n=268) of cotinine
validated smokers were not detected by self reporting
and were therefore not offered smoking cessation ser-
vices (table 4). The number of such undetected smo-
kerswas about three times greater in themost deprived
areas than in the least deprived areas. However, this
represented a smaller proportion of the total number
of cotinine validated smokers in the deprived areas
than in the affluent areas; it seems that a greater propor-
tion of women in affluent areas failed to report their
smoking compared with women in deprived areas.
Although not the focus of this study, the proportion
of cotinine validated smokers in the “unknown” cate-
gory for self reported smoking broadly represented the
distribution across the whole study population.
Projected smoking figures for Scotland
We determined the degree to which our sample was
representative of the screened population, the West
of Scotland population (from which the sample was
drawn), and the Scottish population of pregnant
women (table 5). We found no differences between
the sample population and the screened population in
any of the characteristics examined. Comparing the
sampled population with theWest of Scotland popula-
tion, there were no significant differences in the distri-
bution of self reported smoking or maternal age, but
there were small but significant differences by area
deprivation. The distribution of maternal age within
deprivation categorieswas also compared across popu-
lations and no differences were seen between the
sampled and West of Scotland populations. Compar-
ing the sampled population with the Scottish popula-
tion, there was a significant difference in area
deprivation and self reported smoking but not mater-
nal age. These data showed the need to adjust at least
for differences in self reported smoking and area
deprivation when generating projected figures for
Scotland. Although no differences in the maternal
age distribution were detected, projected figures were
also adjusted for maternal age to account for any resi-
dual confounding that might arise between age cate-
gories.
After adjustment for the distribution of area depriva-
tion, self reported smoking, and maternal age, we esti-
mated the number of pregnant smokers in Scotland to
be 14521 (that is, a smoking prevalence of 27.6%), and
2400 of these would be undetected by self report,
representing 4.6% of the total population of pregnant
women in Scotland. The number of undetected smo-
kers in themost deprived areas (deprivation categories
4+5, n=1196) is nearly twice that in the least deprived
areas (categories 1+2, n=642). Using the projected fig-
ures for Scotland, the prevalence of smoking in the
most deprived areas is 39% compared with 14% in
the least deprived areas.
The distribution of cotinine values produced two
quite distinct populations (see figure in the extra mate-
rial on bmj.com), suggesting that the findings were
robust to the chosen cotinine cut-off value of 13.7 ng/
ml.Using an alternative cut-off of 24 ng/ml21 produced
a prevalence of cotinine validated smoking for the
study population of 29.3% (n=1018), very similar to
the 30.1% produced using the original cut-off (see
extra material on bmj.com for all other data using the
alterative cut-off value).
DISCUSSION
Using cotinine validation to identify smokers, we esti-
mate that 1046 of the 3475women in the study popula-
tion smoked during pregnancy, which is 25% higher
than figures based on self reported smoking (839/
Table 2 | Prevalence of current smoking among 3475 pregnant women in the West of Scotland according to self reported
smoking and cotinine validated smoking
Self reported smoking* Cotinine validated smoking† Difference
No of women
Percentage
(95% CI) No of women
Percentage
(95% CI)
Percentage
points z score P value
Total sample (n=3475) 839 24.1 (22.7 to 25.6) 1046 30.1 (28.6 to 31.6) 6.0 8.27 <0.001
Deprivation category‡:
1+2 (n=985) 101 10.3 (8.5 to 12.3) 142 14.4 (12.3 to 16.7) 4.1 4.23 <0.001
4+5 (n=1753) 587 33.5 (31.3 to 35.7) 706 40.3 (38.0 to 42.6) 6.8 6.03 <0.001
*Measured at booking appointment (8-12 weeks of gestation).
†Measured at about 15 weeks of gestation. Cotinine concentrations ≥13.7 ng/ml were taken to indicate current smoking.
‡Based on Scottish Index of Multiple Deprivation (categories 1+2 are least deprived, 4+5 are most deprived).
Table 3 | Proportion of pregnant women with serum cotinine
concentration above and below the cut-off value for current
smoking by their self reported smoking status. (Values are
numbers (percentages))
Self reported smoking status
Serum cotinine concentration
<13.7 ng/ml ≥13.7 ng/ml
Current (n=839) 61 (7) 778 (93)
Former (n=367) 273 (74) 94 (26)
Never (n=1971) 1875 (95) 96 (5)
Unknown (n=298) 220 (74) 78 (26)
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3475). The projected true smoking prevalence for
pregnant women in Scotland (after adjusting for area
deprivation, maternal age, and self reported smoking)
is 28%, notably higher than the 23% based on self
reporting.2 Projected figures suggest that in Scotland
each year more than 17% of pregnant smokers
(n=2400) are not identified as such and are therefore
not offered smoking cessation services.
There was a striking difference in smoking preva-
lence in pregnant women between area deprivation
categories, reflecting that seen elsewhere.22 Nearly
40%of smokers in the least deprived areas (deprivation
categories 1+2) did not report their smoking status
compared with only 22% of smokers in the most
deprived areas (categories 4+5). This possibly reflects
a greater expectation in more affluent areas that
womenwill quit smoking during pregnancy.However,
because of the larger number of smokers in deprived
areas, in absolute terms, there were three times as
many undetected smokers in the most deprived areas
compared with the least deprived areas in the sample
population.
In our sample, about a quarter of validated smokers
went undetected. This proportion is similar to that seen
in other studies of pregnant women in the UK19 and
elsewhere.6-8 23 Higher proportions of undetected smo-
kers have been seen: in oneUS studymore than 50%of
cotinine validated smokers were undetected by self
reporting.24 High proportions of undetected smokers
(the proportion of smokers who do not report their
smoking) are commonly seen in pregnant populations
involved in cessation programmes,25 26 as might be
expected. Other studies have reported lower propor-
tions of undetected smokers;22 27 some as low as 1%.28
The variation in proportion of undetected smokers can
be largely explained by different populations and set-
tings in which smoking status was reported. The study
that reported only 1% undetected smokers was based
on a Swedish population in which only 8% of the preg-
nant population were smokers,28 whereas the study
reporting over 50% undetected smokers examined a
population in a deprived area with a smoking preva-
lence of 35%.
There is general agreement that serum cotinine is
ideal for measuring smoking status because of its long
half life (9 hours in pregnant women)29 and the proce-
dure’s optimised sensitivity (94%) and specificity
(81%).4 19 There is little variation in the cotinine cut-
off level used to define a pregnant smoker, with some
studies using the lower value of 10 ng/ml727 and others
using values up to 24 ng/ml.821 The results of our study
were robust to the chosen cut-off value.Cotinine is spe-
cific for nicotine, but not necessarily for smoking; both
nicotine replacement therapy and exposure to envir-
onmental tobacco smoke have been shown to elevate
serum cotinine levels. The median cotinine level
recorded in studies measuring the impact of exposure
to environmental tobacco smoke iswell belowour cho-
sen cut-off value of 13.7 ng/ml—a median cotinine
concentration of 4 ng/ml has been reported for office
staff30 and 8 ng/ml for bar staff.31 Therefore, women
exposed to environmental tobacco smoke were unli-
kely to be miscoded as smokers in our study. The
women in this study were pregnant in 2003-4, and
nicotine replacement therapywas not routinely recom-
mended in the West of Scotland until two specialist
smoking cessation programmes began offering it in
2002 (CATCH)32 and 2004 (BREATHE).33 The only
service offering nicotine replacement therapy during
the time the study women were pregnant was
CATCH, which offered it to 65 women. Even if all
these 65 women used nicotine replacement products
the small number of women involved would be unli-
kely to bias our findings greatly. In addition, a smoking
cessation study based in Glasgow during 2001-3
showed that only 0.8% (6/718) of women reported tak-
ing nicotine replacement therapy,34 again suggesting
that any effects of nicotine replacement therapy in the
study population would be minimal.
The recording of self reported smoking status at the
antenatal clinic booking visit usually took place about
threeweeks before the collection of bloodused for coti-
nine analysis. It was possible, therefore, for women to
have quit smoking and correctly report being a former
smoker at the booking appointment but to resume
smoking before the blood was collected. Therefore, it
should be acknowledged that some of the unreported
smokers may have been former smokers who relapsed
after reporting their smoking status and not smokers
deliberately denying their smoking status. This distinc-
tion may not be so important for the objective of this
study—determining the true prevalence of smoking
among pregnant women. Itmay be that, within reason,
the later in pregnancy that smoking is measured the
more accurate it will be in terms of recording the true
number of pregnant smokers—in that it will capture
more of those that relapse.23 As a result, these data
will slightly overestimate the number of current
Table 4 | Cotinine validated current smoking among pregnant women that was undetected (not captured by self reported
smoking status)
No of cotinine validated smokers
No (%) of cotinine validated smokers
not captured by self reporting
Undetected smokers as %
of all pregnant women
Total sample (n=3475) 1046 268 (25.6) 7.7
Deprivation category*:
1+2 (n=985) 142 56 (39.4) 5.7†
4+5 (n=1753) 706 155 (22.0) 8.8
*Based on Scottish Index of Multiple Deprivation (categories 1+2 are least deprived, 4+5 are most deprived).
†z=0.293, P=0.003 for difference in distribution of undetected smokers across deprivation categories 1+2 and 4+5.
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smokers who were not offered smoking cessation ser-
vices because, at the time of asking, the to-be relapsers
were in fact former smokers, although they are argu-
ably in need of such services.
Extrapolation of the sample results to all pregnant
smokers in Scotland is based on two assumptions, the
first being that the study population accurately repre-
sents the population from which it was drawn (West of
Scotland). The study sample is similar to the screened
sample in all characteristics tested, which suggests suc-
cessful random selection of the sample from the
screened population. Differences between the study
population and the West of Scotland will therefore
reflect differences between the screened and non-
screened women. Only if such differences are also
related to the accuracy of self reported smoking will
there be potential to introduce bias; differences that
differentiate screened and non-screened women that
relate only to self reported smoking status but not the
accuracy of self reporting will not introduce bias. The
data suggest that neither self reported smoking status
normaternal age were related to the decision to opt for
screening in this setting (table 5), as the study sample
and the population of the West of Scotland have simi-
lar profiles. A major strength of these data is the high
screening rate (70%of all womenwere screened), redu-
cing the potential for differences between the screened
and target population. Indeed the lack of a maternal
age effect is consistent with the continued monitoring
of this screened population. The sample population
had a slightly different area deprivation profile com-
pared with the population of the West of Scotland
(52% in the West of Scotland from deprivation cate-
gories 4+5 compared with 51% of the sample popula-
tion). However, there is little difference in the
percentages; the significance of the result is related to
the large sample size rather than an important differ-
ence in deprivation profile. Other factors that may be
related to a decision to opt for screening include ethni-
city and religion. Ethnicity is unlikely to have a large
impact on the data as there was very little representa-
tion of black and ethnic minority populations in Scot-
land at the time of data collection (2% non-white
people in the 2001 census, General Register Office
for Scotland). Catholic women are likely to be under-
represented in the screened population. Although
there are substantial numbers of Catholics in Scotland
(about 16% at the 2001 census), it is unlikely that the
accuracy of self reported smoking status provided by
pregnant Catholic women would be substantially dif-
ferent from that of the rest of the population and there-
fore these factors are unlikely to introduce bias. There
may be yet other differences between the population of
screened and non-screened women that we were not
able to investigate that also relate to the accuracy of
self reported smoking. However, given the high
screening rate (70%), these differences are unlikely to
bias the findings significantly.
The second assumption made is that differences
between theWest of Scotland and the Scottish popula-
tion that also relate to the accuracy of self report are
accounted for in generating the projected figures. Dif-
ferences between the pregnant women from these two
populations are expected because theWest of Scotland
includes some of the more deprived areas of the
Table 5 | Distribution of maternal age, area deprivation, and self reported smoking status
among pregnant women in the study sample, the screened sample, the West of Scotland,
and Scotland. (Values are numbers (percentages) unless stated otherwise)
All
Pregnant women (2004 birth)*
Studysample
(n=3475)
Screened
population
(n=20283†)
West of Scotland‡
(n=29 975)
Scotland
(n=52862)
Self reported smoking status§
Current 839 (24) 4896 (24) 7303 (25) 12 366 (24)
Former 367 (11) 2072 (10) 2770 (9) 4712 (9)
Never 1971 (57) 11 353 (56) 16 980 (57) 30 680 (59)
Unknown 298 (9) 1962 (10) 2614 (9) 4074 (8)
Difference from study sample — χ2=4.4, P=0.2 χ2=5.5, P=0.1 χ2=13.3, P=0.004
Deprivation category (Scottish Index of Multiple Deprivation)
1+2 985 (28) 5683 (28) 8738 (29) 19621 (37)
3 733 (21) 4028 (20) 5601 (19) 9825 (19)
4+5 1753 (51) 10 531 (52) 15 636 (52) 23 145 (44)
Difference from study sample¶ — χ2=4.5, P=0.3 χ2=17.4, P<0.002 χ2=130, P<0.001
Maternal age (years) by deprivation category
Categories 1+2:
<20 21 (2) 140 (3) 235 (3) 528 (3)
20-24 74 (8) 505 (9) 770 (9) 1753 (9)
25-29 220 (22) 1243 (22) 1836 (21) 4360 (22)
30-34 390 (40) 2246 (40) 3455 (40) 7744 (40)
35-39 244 (25) 1354 (24) 2085 (24) 4395 (22)
≥40 36 (4) 193 (3) 357 (4) 764 (4)
Difference fromstudysample — χ2=2.8, P=0.7 χ2=4.2, P=0.5 χ2=5.7, P=0.3
Category 3:
<20 38 (5) 188 (5) 303 (5) 586 (6)
20-24 117 (16) 642 (16) 882 (16) 1629 (17)
25-29 188 (26) 1084 (27) 1452 (26) 2568 (27)
30-34 230 (31) 1270 (32) 1835 (33) 3068 (32)
35-39 138 (19) 741 (18) 959 (17) 1529 (16)
≥40 22 (3) 101 (3) 170 (3) 306 (3)
Difference fromstudysample — χ2=1.4, P=0.9 χ2=1.6, P=0.9 χ2=5.4, P=0.4
Categories 4+5:
<20 215 (12) 1205 (12) 1907 (12) 3026 (13)
20-24 430 (25) 2672 (25) 4052 (26) 6318 (27)
25-29 464 (27) 2774 (26) 4018 (26) 5922 (25)
30-34 411 (24) 2434 (23) 3575 (23) 5211 (22)
35-39 197 (11) 1258 (12) 1763 (11) 2444 (10)
≥40 35 (2) 177 (2) 321 (2) 450 (2)
Difference fromstudysample — χ2=2.9, P=0.7 χ2=1.8, P=0.9 χ2=7.2, P=0.2
All categories combined:
Difference fromstudysample — χ2=3.1, P=0.7 χ2=4.4, P=0.5 χ2=3.6, P=0.6
*Excluding home births and births at non-NHS hospitals.
†Refers to those screening records that could be linked with their obstetric records from the Scottish Morbidity
Records (SMR02).
‡Made up of Argyll and Clyde, Ayrshire and Arran, Dumfries and Galloway, Forth Valley, Greater Glasgow,
Highland, Lanarkshire, and Western Isles health boards.
§Smoking figures for West of Scotland are for 2005.
¶Collapsed categories are used for χ2 test.
Missing data: Sample population—4 records with no deprivation data, 1 record with no maternal age; screened
population—18 records with no maternal age, 787 (3.7%) with no deprivation data, 746 with no self reported
smoking data (that is, not linked records); West of Scotland—38 with no region data; Scottish data—163 with
no deprivation data.
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country. The projected figures take account of area
deprivation, smoking status, and maternal age, which
probably accounts for the major differences between
east and west Scotland. Again religion (Catholicism
in the West of Scotland) is unlikely to be related to
the accuracy of self report.
Some errors in the recording or transcribing of the
self reported smoking status at the booking appoint-
ment will have happened. It is not likely that these
recording errors would be systematic (that is, by depri-
vation or smoking status), and such errors are therefore
unlikely to bias these finding away from the null
hypothesis. The recording of self reported smokers
with a serum cotinine concentration below the cut-off
value for non-smokers may slightly underestimate the
true prevalence of smokers.
For 9% of the routinely collected data used for this
study there was no valid information about self
reported smoking status (the information was either
not requested or not recorded), compounding the pro-
blem of inaccurate self reported data. There is some
evidence that the issue of smoking is not necessarily
givenhighpriority in the relationshipbetweenmidwife
and expectant mother,14 possibly explaining cases of
missing data. Similar problems with data quality have
also been highlighted with routinely collected self
reported data in other regions.35 The poor quality and
accuracy of routinely collected self reported smoking
data in pregnant women shown in this study and
elsewhere35 call for better methods of routinely identi-
fying smokers during pregnancy. The current policy in
Glasgow is for all women to provide self reported
smoking status and undergo a carbon monoxide
breath test at maternity booking. If implemented
fully, this could increase the identification of pregnant
smokers from 75% to about 95%.33 36 Further studies
are required to determine if offering routine biochem-
ical validation (such as carbon monoxide breath tests)
to all pregnant women at maternity booking would be
the most cost effective method to identify smokers, to
monitor targets, and to increase the reach of specialist
smoking cessation support. Accurate smoking infor-
mation also refines the estimation of individual fetal
risks of Down’s syndrome by prenatal screening,
since maternal smoking causes changes in the levels
of the biochemical markers used in the screening
test37 (discussed further in a subsequent paper).
In conclusion, reliance on self reporting to measure
smoking during pregnancy significantly underesti-
mates the number of pregnant smokers in Scotland,
with more than 2400 unrecognised pregnant smokers
a year who will not be offered smoking cessation ser-
vices. Reliance on self reporting resulted in twice as
many undetected smokers in the most deprived areas
compared with the least deprived areas. Overall, these
figures call for more accurate methods of identifying
pregnant smokers, especially when such data are used
to inform policy and provide patient care.
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